FDA Approved: DALBAVANCIN — Original Application (Meitheal Pharmaceuticals Inc)

View source ↗

Summary

FDA approves Meitheal Pharmaceuticals' generic dalbavancin for the treatment of acute bacterial skin and skin structure infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections

Drugs mentioned

• Dalbavancin (dalbavancin)

Snippet

ORIG AP for DALBAVANCIN (DALBAVANCIN)